Germany's Medica 2017 Kicks Off Amid Changeable Outlook, As MDR Clouds Scud Into View

Germany's medtech industry is yet to find out who will hold the political reins for health care and the other ministerial portfolios that influence the market access and innovation support mechanisms for medtech products. Meanwhile, in the run-up to Medica 2017, German manufacturers were reporting both moderate business growth and increasing concern about reimbursement issues and the EU MDR and IVDR, which are making life less predictable for medtech innovators.